SVB Leerink Sees ‘Cheaper Way’ To Pharma Digital Marketing With This Stock
SVB Leerink initiated coverage on OptimizeRx Corporation (NASDAQ:OPRX) with a buy rating and a price target of $38, implying an upside of…
HC Wainwright Rating & Price Target On TherapeuticsMD Under Review On ‘Unclear Path’
The merger agreement between EW Partners and TherapeuticsMD Inc (NASDAQ:TXMD) was terminated, with EW Partners not acquiring the majority of shares…
HC Wainwright Reiterates On Pluristem After Encouraging Initial Data
Yesterday Pluristem Therapeutics Inc (NASDAQ: PSTI) announced top-line results from its Phase 3 trial evaluating PLX-PAD in 240 patients for muscle recovery following hip fracture surgery.
Alnylam Hits Moderna With Another Patent Infringement Suit-Related To COVID-19 Vaccine
Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) added one more patent infringement lawsuit against Moderna Inc (NASDAQ:MRNA), claiming it violated a newly obtained patent. The…
Ericsson’s $6.2B Vonage Buyout Receives US Panel’s Clearance
Telefonaktiebolaget LM Ericsson (NASDAQ:ERIC) received clearance from the Committee on Foreign Investments in the U.S. to complete its acquisition of Vonage Holdings…
Why Codexis Shares Are Slumping Today
Codexis Inc (NASDAQ:CDXS) expects Q2 sales of approximately $38 million and FY22 sales of 135 million to $141 million, below the…
UnitedHealth Q2 Earnings Surpass Street View Led By Growth In Both Segments, Lifts FY22 Earnings Outlook
UnitedHealth Group Inc (NYSE:UNH) has reported Q2 FY22 sales of $80.3 billion, up 13% Y/Y, beating the consensus of $79.68…
Beigene’s Inspections Delay Suggest Eventual Approval, Says This Analyst
Beigene Limited (NASDAQ: BGNE) provided a regulatory update on the anticipated US approval decision for the Biological License Application for tislelizumab in 2L metastatic esophageal squamous cell carcinoma (ESCC).
SVB Likes This ‘Novel Antipsychotic’-Focused Stock
SVB Leerink initiated coverage on Karuna Therapeutics Inc (NASDAQ:KRTX) with an Outperform rating and a price target of $170. SVB notes that…
Moderna’s COVID-19 Vaccine Scores Canadian Approval For Kids Below 5 Years
Health Canada has approved the use of Moderna Inc’s (NASDAQ:MRNA) mRNA COVID-19 vaccine, Spikevax, in a two-dose series of 25 µg…